EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: March 2016

Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders

March 22, 2016

Hamburg, Germany, 22 March 2016 – Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This

Read »

Edinburgh Molecular Imaging Ltd Awarded Innovate UK Grant to Qualify the Role of EMI-137 in Colorectal Cancer Lesion Detection

March 9, 2016

Edinburgh, United Kingdom, 9th March, 2016 – Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the

Read »

EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: March 2016

Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders

Edinburgh Molecular Imaging Ltd Awarded Innovate UK Grant to Qualify the Role of EMI-137 in Colorectal Cancer Lesion Detection

Categories

Archives